Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma
Stopped: Lack of patient enrollment
United States7 participantsStarted 2014-03
Plain-language summary
We assess the effectiveness of percutaneous ethanol ablation for the treatment of thyroid cancer.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18 years and older
* Diagnosis: single, cytology-proven papillary thyroid carcinoma measuring 1 cm or less in diameter (microcarcinoma, T1a), without visible extrathyroidal extension, and with negative central and lateral neck lymph nodes by ultrasound
Exclusion Criteria:
* Patient refusal to participate
* History of prior thyroid or parathyroid surgery
* Previous recurrent laryngeal nerve injury
* Inability to make decisions or comply with follow up
* Co-existing indication for thyroidectomy
* Aggressive cytological or molecular features
* Multifocal papillary thyroid carcinoma
* Pregnant or breast-feeding
* Anatomically unfavorable location of the tumor (proximity to recurrent laryngeal nerve or trachea)
* Documented or suspected distant metastasis
* History of radiation to neck or face
* Family history of thyroid cancer